Hydrofarm Group (HYFM) Q4 2024 earnings summary

Executive summary

• Q4 net sales declined 20.9% year-over-year to $37.3 million, with full-year sales at $190.3 million, impacted by industry oversupply and retail closures.

• Net loss increased to $17.5 million in Q4 and $66.7 million for the year, driven by lower sales and inventory charges.

• Adjusted EBITDA was negative at $(7.3) million for Q4 and $(5.2) million for the year, reflecting industry headwinds and lower gross margins.

• Proprietary brand sales mix improved from 35% in 2020 to 56% in 2024, supporting profitability in most quarters.

• Cost management initiatives led to a 16.9% reduction in adjusted SG&A for the year, with $9 million in annual savings.

Financial highlights

• Q4 gross profit was $1.8 million (4.9% margin), down from $8.4 million (17.9%) last year; adjusted gross profit was $3.6 million (9.6% margin), down from $11.5 million (24.3%).

• Full-year gross profit margin improved slightly to 16.9%, but adjusted gross margin decreased to 21.2%.

• Q4 adjusted EBITDA loss was $7.3 million, attributed to lower sales and gross profit, partially offset by SG&A savings.

• Q4 free cash flow was $2.4 million; full-year free cash flow was negative $(3.2) million.

• Cash balance at year-end was $26.1 million, with $128 million total debt and $39 million total liquidity.

Outlook and guidance

• 2025 net sales expected to decline 10–20% year-over-year, but adjusted gross profit margin is projected to increase due to improved proprietary brand mix and cost savings.

• Adjusted EBITDA expected to remain negative but improve versus 2024, with further SG&A reductions and operational efficiencies.

• Free cash flow expected to improve in 2025 through inventory reductions and better working capital management.

• Capital expenditures projected below $2 million for 2025.

• No significant non-restructuring inventory or receivable charges anticipated for 2025.